WELCIA HOLDINGS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,151 JPY | +0.96% |
|
-0.72% | -12.77% |
| Sales 2025 * | 1,278B 8.14B | Sales 2026 * | 1,339B 8.53B | Capitalization | 440B 2.8B |
|---|---|---|---|---|---|
| Net income 2025 * | 27.35B 174M | Net income 2026 * | 29.39B 187M | EV / Sales 2025 * | 0.37 x |
| Net Debt 2025 * | 36.52B 232M | Net Debt 2026 * | 8.61B 54.81M | EV / Sales 2026 * | 0.34 x |
| P/E ratio 2025 * |
16.1
x | P/E ratio 2026 * |
15
x | Employees | 15,286 |
| Yield 2025 * |
1.69% | Yield 2026 * |
1.78% | Free-Float | 42.22% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.84% | ||
| 1 week | -0.81% | ||
| Current month | -0.83% | ||
| 1 month | -6.55% | ||
| 3 months | -19.95% | ||
| 6 months | -16.60% | ||
| Current year | -12.88% |
1 week
2 117.50
2 161.00
1 month
2 095.002 329.00
Current year
2 095.003 030.00
1 year
2 095.003 113.00
3 years
2 095.004 390.00
5 years
2 060.005 035.00
10 years
740.255 035.00
| Managers | Title | Age | Since |
|---|---|---|---|
Norimasa Sato
DFI | Director of Finance/CFO | 67 | 08-08-31 |
Takamitsu Ikeno
CHM | Chairman | 80 | 08-08-31 |
Takashi Abe
BRD | Director/Board Member | 63 | 11-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Motoya Okada
BRD | Director/Board Member | 73 | 14-10-31 |
Takamitsu Ikeno
CHM | Chairman | 80 | 08-08-31 |
Hideharu Mizuno
BRD | Director/Board Member | 70 | 10-10-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.39% | 13 M€ | +9.47% | ||
| 0.23% | 2 M€ | -.--% | - | |
| 0.23% | 2 M€ | +9.19% | - | |
| 0.15% | 10 M€ | +16.91% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-10 | 2,151 | +0.96% | 339 600 |
| 24-06-07 | 2,130 | +0.31% | 416,200 |
| 24-06-06 | 2,124 | -0.49% | 463,300 |
| 24-06-05 | 2,134 | -0.54% | 557,200 |
| 24-06-04 | 2,146 | -0.92% | 555,800 |
Delayed Quote Japan Exchange, June 10, 2024 at 01:55 am EDT
More quotes
Welcia Holdings Co Ltd is a Japan-based company mainly engaged in the retail business focusing on pharmaceuticals, preparations, cosmetics. The Company is engaged in the provision of the retail business based on a drug store. The Company is mainly engaged in the sale of pharmaceuticals, hygiene care products, baby products, health foods, preparations, cosmetics, household miscellaneous goods and foods.
Sector
Drug Retailers
Calendar
2024-07-03
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
2,130
JPY
Average target price
2,588
JPY
Spread / Average Target
+21.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.88% | 2.81B | |
| -39.33% | 13.67B | |
| -8.96% | 7.95B | |
| +4.90% | 5.86B | |
| -14.08% | 5.71B | |
| -3.07% | 4.6B | |
| +70.58% | 4.5B | |
| -8.29% | 3.77B | |
| -22.05% | 3.05B | |
| -11.32% | 2.57B |
- Stock Market
- Equities
- 3141 Stock
